Lilly’s Investigational Alzheimer’s Therapeutic Gets Breakthrough Therapy Designation June 25, 2021 Auto Bot News 0 FDA has granted breakthrough therapy designation to donanemab, Eli Lilly and Co.’s investigational antibody treatment for Alzheimer’s disease.
